Product Details
Myalepta
Metreleptin11.3 mg/Vial
Powder for Solution for Subcutaneous Injection
5-mL Single-Use Vial
DIN/PIN/NPN
02544571
Manufacturer
Amryt Pharmaceuticals DAC
Formulary Listing Date
2026-06-05
Unit Price
3120.4100
Amount MOH Pays
3120.4100
Coverage Status
Exceptional Access Program Product
ODB Formulary Therapeutic Classification
Therapeutic Note
NO
ATC Code
A16AA07
Interchangeable Products
NOLU Clinical Criteria
NORequirements
EAP Criteria
| Therapeutic Class | Reimbursement Criteria |
|---|---|
| Unclassified EAP Drugs | These drugs are not currently listed in the Exceptional Access Program Reimbursement Criteria for Frequently Requested Drugs – January 1, 2025 Edition Physicians may wish to contact the EAP directly by phone at 416-327-8109 or 1-866-811-9893 or by email at EAPFeedback.MOH@ontario.ca to see if an unlisted drug product and/or indication may be considered for EAP funding. |